[email protected] +92-51-884-0600

Dr. Qura Tul Ain

PROFILE SUMMARY

Dr. Qura Tul Ain is an Assistant Professor in the Department of Biosciences at Shifa Tameer-e-Millat University, Islamabad. She is a biochemist and molecular geneticist who completed her PhD in 2026 focusing on the molecular mechanisms behind familial hypercholesterolemia and severe hypertriglyceridemia. Her research explores the genetics and epidemiology of inherited lipid disorders in Pakistani populations, integrating laboratory-based molecular genetics with large clinical and population datasets. She has authored 26 peer-reviewed publications, actively collaborating with research groups in Slovenia, and has presented her research at international conferences across Pakistan and Oman. She is an EAS Young Fellow (2026–2028) and an invited speaker in the EAS Lipid Clinic Network webinar series.

EDUCATIONAL QUALIFICATIONS

DegreeDiscipline / SpecialtyInstitutionYear
PhDBiochemistry & Molecular BiologyCOMSATS University, Islamabad2026
B.EdEducationAllama Iqbal Open University, Islamabad2018
M.PhilBiochemistry & Molecular BiologyQuaid-i-Azam University, Islamabad2013
M.ScBiochemistryPMAS-Arid Agriculture University, Rawalpindi2011
B.ScMedical Laboratory Technology (First Position)University of Health Sciences, Lahore2009

TEACHING & ACADEMIC EXPERIENCE

Designation / RoleInstitution / OrganizationDuration
Assistant ProfessorDepartment of Biosciences, Shifa Tameer-e-Millat University (STMU), IslamabadSept 2026 – Present
Assistant ProfessorBashir Institute of Health Sciences (BIHS), IslamabadMar 2025 – Aug 2026
Research AssistantShifa Tameer-e-Millat University (STMU), Islamabad2019 – 2025
LecturerMedical Laboratory Technology (MLT), STMU, Islamabad2015 – 2017
LecturerBiochemistry & Molecular Biology, University of Gujrat, Sialkot Sub-Campus2014 – 2015

MANAGEMENT EXPERIENCE

Designation / RoleInstitution / OrganizationDuration
Coordinator, MLTBashir Institute of Health Sciences (BIHS), IslamabadMar 2025 – Aug 2026

HONORS & AWARDS

  • EAS Young Fellowship Program: European Atherosclerosis Society (2026–2028).
  • Best Teacher Award: Khyber Medical University, Peshawar (2025).
  • Asia-Pacific Award: Awarded travel grant to attend the IAS Conference on Atherosclerosis, Muscat, Oman (2024).
  • Vice Chancellor’s Award: PMAS-Arid Agriculture University, Rawalpindi.
  • Fellowship Award: Quaid-i-Azam University, Islamabad.
  • Academic Distinction: First position in B.Sc. Medical Laboratory Technology across the University of Health Sciences and all its affiliated institutes in Pakistan.

RESEARCH AREAS & INTERESTS

  • Molecular genetics of lipid metabolism disorders
  • Familial Hypercholesterolemia
  • Lipoprotein lipase deficiency
  • Molecular diagnostics
  • Cardiovascular disease genetics

JOURNAL PUBLICATIONS

  1. Ain Q, Khan M, Azhar N, Sikonja J, Rana MA, Shafi S, et al., Groselj U. CREB3L3 associated severe hypertriglyceridemia: targeted NGS identification of a novel truncating variant and systematic review. Orphanet Journal of Rare Diseases, 2026.
  2. Ain Q, Khan M, Nawaz A, Ali Z, Sikonja J, Khan MI, et al., Groselj U. Prevalence and Clinical Characteristics of Probable Familial Chylomicronaemia Syndrome (FCS) at a Tertiary Care Centre in Pakistan: Insights from a Hospital-Based Screening Study. Journal of Clinical Lipidology, 2026.
  3. Ain Q, Khan M, Nawaz A, Batool H, Khan MI, Ajmal M, Sadiq F. Trends and Prevalence of Severe Hypertriglyceridemia in Pakistan: A Five-Year Analysis (2019–2023). Journal of Clinical Lipidology, 2025.
  4. Ain Q, Nawaz A, Khan M, Sikonja J, Batool H, Zaheer R, Khan MI, Ajmal M, Sadiq F, Groselj U. Dyslipidaemia among children and adolescents in Pakistan: a five-year retrospective cohort study based on laboratory data. Lipids in Health and Disease, 2025; 24(1):110.
  5. Ain Q, Sikonja J, Sadiq F, Shafi S, Kafol J, Gorjanc T, et al., Groselj U. Cascade Screening of a Pakistani Consanguineous Familial Hypercholesterolemia Cohort: Identification of Seven New Homozygous Patients. Atherosclerosis, 2025.
  6. Ain Q, Cevc M, Marusic T, Sikonja J, Sadiq F, Sustar U, et al., Groselj U. Genetic and clinical characteristics of patients with lipoprotein lipase deficiency from Slovenia and Pakistan: case series and systematic literature review. Frontiers in Endocrinology, 2024; 15:1387419.
  7. Ain Q, Khan M, Afrah A, Akmal Z, Javed S, Nawaz A, Khan I, Sadiq F. Side effects of COVID-19 vaccination in Pakistani population: A cross-sectional study. Bangladesh Medical Journal, 2024; 23(2).
  8. Khan M, Ain Q, Sikonja J, Kern BC, Batool H, Khan SA, Hayat MQ, Khan MI, Groselj U, Sadiq F. Early Mortality in Children with Homozygous Familial Hypercholesterolemia: Case Reports of Deaths at Ages Five and Seven and a Systematic Review of Global Evidence. Journal of Clinical Lipidology, 2025.
  9. Khattak UK, Sadiq F, Shah SN, Rehman HU, Ain Q. Occupational health hazards, health conditions and safety measures among sanitation workers in Khyber Pakhtunkhwa, Pakistan. Khyber Medical University Journal, 2025; 17(3):286–92.
  10. Tahir S, et al. Potential Therapeutic Compounds Against Hypercholesterolemia: An in-Silico Analysis. Khyber Medical University Journal, 2025; 17(2):213–22.
  11. Khan M, Ain Q, Sikonja J, Batool H, Hayat MQ, Khan MI, Groselj U, Sadiq F. Prevalence of Familial Hypercholesterolemia in Pakistan: A Pooled Analysis of 1.5 Million Individuals and Comparison with Other Countries of the Region. Global Heart, 2025; 20(1).
  12. Nawaz A, Khan M, Ain Q, Amjad M, Sikonja J, Batool H, Khan MI, Groselj U, Sadiq F. Gender Disparity in Lipid Testing Among Over 0.5 Million Adults from Pakistan. Global Heart, 2025; 20(1):16.
  13. Batool H, Khan M, Ain Q, Chughtai OR, Khan MD, Khan MI, Sadiq F. Frequency of lipoprotein (a) testing and its levels in Pakistani population. Global Cardiology Science & Practice, 2024(4):e202437.
  14. Azim T, Khan AH, Sadiq F, Sulaiman SAS, Khan A, Ain Q. Impact of COVID-19 on nephropathy in diabetes mellitus type–II patients: a systematic literature review and meta-analysis. BMC Nephrology, 2024; 25(1):399.
  15. Nawaz A, Khan M, Ain Q, Batool H, Khan MD, Khan MI, Sadiq F. A modified equation for calculating low density lipoprotein cholesterol in Pakistani population. Khyber Medical Journal, 2023; 15(4).
  16. Khan M, Majeed S, Ain Q, Nawaz A, Sumra K, Lammi V, Nihal F, Afrah A, Khan EA, Khan I, Sadiq F. Long COVID in Pakistan: a cross-sectional analysis of health and psychosocial outcomes. Psychology, Health and Medicine, 2023: 1–15.
  17. Ganna A, et al., Ain Q. A second update on mapping the human genetic architecture of COVID-19. Nature, 2023; 621(7977).
  18. Sadiq F, Shafi S, Sikonja J, Khan M, Ain Q, Khan MI, et al., Zehra T. Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study. The Lancet Regional Health – Southeast Asia, 2023; 12.
  19. Ain Q, Awais S, Khan M, Awais S, Raja AKF, Khan MI, Sadiq F. Efficacy of Paracetamol or Ibuprofen in The Management of COVID-19 Fever: A Systematic Review. Journal of Islamic International Medical College (JIIMC), 2023; 18(1):63–74.
  20. Khan M, Ain Q, Nawaz A, Khan MI, Sadiq F. Indirect calculation of LDL using thirteen equations in Pakistani population. Clinica Chimica Acta, 2022; 536:77–85.
  21. Bibi H, Shahid T, Ain Q. Search for the Natural Remedies for the Treatment of Gout. Phytopharmacological Communications, 2(02):193–204.
  22. Farooq N, Shoaib M, Ain Q, Farooqi ZR, Asad MJ, Shahzad A. Diagnosis of Urinary Tract Infection: Medical Imaging or Laboratory Based. Pak J Med Res, 2017; 56(4).
  23. Amber M, Shoaib M, Rehman A, Zafar MM, Ain Q, Naseer F, Lodhi RA. Comparative study of causative agents of UTI among indoor, outdoor, children and adult patients of Pakistani population. Bull. Env. Pharmacol. Life Sci., 2016; 5(8):56–63.
  24. Tariq R, Shoaib M, Umer A, Asad MJ, Ain Q, Zafar MM, Naseer F. Prevalence of HBV, HCV and co-infection with HBV and HCV among the Pregnant Women of Pakistani Population. Adv. Biomed. Pharma., 2016; 3(3):161–165.
  25. Saleem M, Javed F, Naseer F, Furrakh M, Naz H, Ahmad T, Ain Q, Yaseen I. HPLC analysis and Screening of aqueous Methanolic extract of Callestimon viminalis leaves against gentamicin induced nephrotoxicity. Bull. Env. Pharmacol. Life Sci., 2016; 5(9):28–34.
  26. Perveen N, Ahmed KZ, Ahmad S, Ain Q, Shoaib M, Ashraf S, Kausar S, Shehzad A, Shafi A, Babar A, Naseer F. Evaluation of acute and sub-acute hepatotoxic activity of leaves of Ehretia laevis n-hexane extract in mice. ARC Journal of Pharmaceutical Sciences (AJPS), 2016; 2(1):32–36.

CONFERENCE PUBLICATIONS & ABSTRACTS

  1. Ain QT, Sadiq F, Khan M, Batool H, Khan MI, Ajmal M. Prevalence of Hypertriglyceridemia in Pakistan Adult Population: A Cross-Sectional Study. Atherosclerosis, 2024; 399:118658.
  2. Khan M, Sadiq F, Ain Q, Batool H, Khan MI, Hayat MQ. Familial Hypercholesterolemia Among Pediatric Population in Pakistan: A Cross-Sectional Study. Atherosclerosis, 2024; 399:118663.
  3. Sadiq F, Groselj U, Ain Q, et al., Khan MI. Genetic screening of familial hypercholesterolemia cohort from Pakistan. Accepted for European Atherosclerosis Society (EAS) Congress, 2024.
  4. Sadiq F, Khan S, Khan M, Shareef A, Khan H, Ain Q, Khan MI. Potential therapeutic compounds against Hypercholesterolemia: an in-silico analysis. Atherosclerosis, 2023; 379:S172.
  5. Sadiq F, Shafi S, Khan M, Ain Q, Khan I, Rehman H, Sikonja J, Mlinaric M, Gidding S, Groselj U. Mapping of familial hypercholesterolemia basic infrastructure in Pakistan. Atherosclerosis, 2022; 355:95.
  6. Khan M, Ain QT, Aslam M, Khan MI, Sadiq F. Patterns of Lipid profile and the risk of Familial Hypercholesterolemia in Pakistani population: A hospital-based study. J. Diabetes Endocr Pract., 2021.
  7. Ain QT, Khan M, Aslam M, Khan MI, Sadiq F. Clinical outcomes of extreme phenotype COVID-19 patients with Diabetes Mellitus. J. Diabetes Endocr Pract., 2021.